Bertina R M, Van Der Linden I K
J Lab Clin Med. 1982 Nov;100(5):695-704.
A genetic variant of blood coagulation factor IX has been isolated from the plasma of a patient with severe hemophilia B (congenital factor IX deficiency). The isolated variant--factor IX Zutphen--has a strongly reduced affinity for binding of Ca2+, it cannot be cleaved proteolytically by factor XIa, and it has a molecular weight of about 90,000, which is much higher than the 65,000 found for normal factor IX and acarboxy factor IX. Available data indicate that these unique properties of factor IX Zutphen are connected with the presence of an extra polypeptide (molecular weight 33,000) that is linked to the factor IX molecule by a disulfide bond and thus prevents effective binding of Ca2+ or factor XIa. Such a model might explain the extremely low specific coagulant activity of factor IX Zutphen.
已从一名重度B型血友病(先天性因子IX缺乏症)患者的血浆中分离出血液凝固因子IX的一种基因变体。分离出的变体——祖芬因子IX——对Ca2+的结合亲和力大幅降低,不能被因子XIa进行蛋白水解切割,其分子量约为90,000,远高于正常因子IX和无羧基因子IX的65,000。现有数据表明,祖芬因子IX的这些独特特性与一种额外多肽(分子量33,000)的存在有关,该多肽通过二硫键与因子IX分子相连,从而阻止了Ca2+或因子XIa的有效结合。这样的模型或许可以解释祖芬因子IX极低的比凝血活性。